Evidence map›Paper›PMID 35305827›Full record

ArticleVaccine2022

Public opinion on global distribution of COVID-19 vaccines: Evidence from two nationally representative surveys in Germany and the United States.

Matthias Klumpp, Ida G Monfared, Sebastian Vollmer

Open access · greenAbstract read
In one paragraph

Article in Vaccine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Matthias KlumppGeorg-August-University of Göttingen, Department of Business Administration, Chair for Production and Logistics, Platz der Göttinger Sieben 3, 37073 Göttingen, Germany.
Ida G MonfaredGeorg-August-University of Göttingen, Department of Economics, Centre for Modern Indian Studies, Waldweg 26, 37073 Göttingen, Germany. Electronic address: ida.gohardoustmonfared@uni-goettingen.de.
Sebastian VollmerGeorg-August-University of Göttingen, Department of Economics, Centre for Modern Indian Studies, Waldweg 26, 37073 Göttingen, Germany.
University of Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite ongoing calls for a more even global distribution of COVID-19 vaccines, there remains a great disparity between high- and low-income countries. We conducted representative surveys among the adult populations in the United States (N = 1,000) and Germany (N = 1,003) in June 2021 to assess public opinion in these countries on the distributive justice of COVID-19 vaccines. We conducted two instances of analytic hierarchy processes (AHP) to elicit how the public weighs different principles and criteria for vaccine allocation. In further discrete choice experiments, respondents were asked to split a limited supply of vaccine doses between a hypothetical high-income and a hypothetical low-income country. AHP weights in the United States and Germany were 37.4% (37.2-37.5) and 49.4% (49.2-49.5) for "medical urgency", 32.7% (32.6-32.8) and 25.4% (25.2-25.5) for "equal access for all", 13.7% (13.6-13.8) and 13.3% (13.2-13.4) for "production contribution", and 16.3% (16.2-16.4) and 12.0% (11.9-12.1) for "free market rules", respectively, with 95% CI shown in parentheses. In the discrete choice experiment, respondents in the United States and Germany split available vaccine doses such that the low-income country, which was three times more populous than the high-income country, on average received 53.9% (95% CI: 52.6-55.1) and 57.5% (95% CI: 56.3-58.7) of available doses, respectively. When faced with a dilemma where a vulnerable family member was waiting for a vaccine, 20.7% (95% CI: 18.2-23.3) of respondents in the United States and 18.2% (95% CI: 15.8-20.6) in Germany reduced the amount they allocated to the low-income country sufficiently to secure a vaccine for their family member. Our results indicate that the public in the United States and Germany favours utilitarian and egalitarian distribution principles of vaccines for COVID-19 over libertarian or meritocratic principles. This implies that political decisions favouring higher levels of redistribution would be supported by public opinion in these two countries.

Indexed as

COVID-19COVID-19 VaccinesAdultGermanyHumansPublic OpinionSurveys and QuestionnairesUnited StatesCOVID-19 VaccinesCOVID-19Distributive justiceGlobal vaccination

Identifiers

PMID35305827
PMCPMC8890975
OpenAlexW4214838313

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.